Delhi High Court's division bench reserves verdict on Novo Nordisk's appeal against order allowing Dr Reddy's and Sun Pharma to export generic semaglutide. Decision will impact India's growing diabetes drug market.
Tesla CEO Elon Musk confirms he hasn't sold any Tesla shares for three years, instead purchasing $1 billion worth. SEC filings back his claim as Tesla opens a major lithium refinery.
Hero MotoCorp patents the design of its upcoming Vida VXZ electric motorcycle, co-developed with Zero Motorcycles. The streetfighter-style bike features unique styling and advanced components, hinting at a launch later this year or in 2027.
India has multiple legal tools under its Patents Act to address public health concerns while complying with international agreements. This analysis explores how the country can prevent patent abuse.
A Tesla patent highlighting four Indian-origin engineers unexpectedly triggered a heated political debate about H-1B visas and immigrant contributions to American innovation.
Chinese AR glasses maker Xreal files lawsuit against competitor Viture in Texas federal court, alleging patent infringement on key technologies ahead of Apple's expected market entry.
Indian pharma companies face margin pressure from Revlimid patent expiry and US competition, but strong domestic sales and core business momentum may cushion the blow in Q3 FY26.
Oscar-winning actor Matthew McConaughey has registered his voice and image with US patent authorities to prevent unauthorized AI use. His legal team explains this proactive move aims to protect his identity and capture value from new technology.
Patent laws designed for slower eras now hinder progress as AI accelerates discovery. Historical examples show how extended monopolies block innovation.
Delhi High Court overturns injunction, allowing Zydus Lifesciences to manufacture and sell biosimilar of Nivolumab, making cancer treatment 70% cheaper in India.
Delhi High Court permits Zydus Lifesciences to sell its biosimilar of cancer drug Nivolumab until patent expiry in May 2026. Court mandates detailed sales records to protect innovator Squibb's interests. Read more.
Facing 50% US tariffs, India aggressively pursues new trade pacts with UK, EU, and others to diversify exports and safeguard its manufacturing ambitions. Explore the strategy and key deals.
Get the latest live updates from across India. Stay informed on breaking news, political developments, economic shifts, and major events shaping the nation today.
Perplexity Patents, an AI-powered tool, helps innovation teams validate ideas and explore patent landscapes using natural language, preventing costly late-stage discoveries. Discover how it streamlines R&D.
Mandya Institute of Medical Sciences announces 6 joint patent applications for AI-driven cancer detection tech, marking a major step in establishing a Medical AI & Robotics hub in Karnataka. Discover the breakthrough.
MEA clarifies India's engagement with US lobbying firms is a standard diplomatic practice to strengthen outreach. Get the full details on the FARA filings and government's stance.
BMW Group India achieves its highest-ever annual car sales in 2025, selling 18,001 units. Electric vehicle sales skyrocket by 200%, contributing 21% to total sales. Read the full analysis.
India's exports to China surged 33% to $12.22 billion from April-November 2024-25, driven by electronics, agriculture, and metals. This marks a structural shift as trade with the US faces high tariffs. Read more.
FARA filings reveal Pakistan's intense US lobbying to secure FATF whitelist after India's 2019 Balakot strikes. Discover the details and implications.
US FARA filings expose Pakistan's intense lobbying in Washington to stop India's military response after Pahalgam. Over 60 contacts revealed. Read the full story.
Natco Pharma files suit in Delhi High Court seeking revocation of Novo Nordisk's patent on diabetes drug semaglutide. Court issues notice, hearing set for Feb 5. Indian pharma race for generic Ozempic heats up.
SIB SHInE at KGMU, with IIT-Kanpur, patents a wearable sensor for early breast abnormality detection. A breakthrough in med-tech innovation. Read about the collaborative triumph.
FARA filings reveal intense lobbying by India & Pakistan in Washington during Operation Sindoor pause. India hired Trump insiders, while Pakistan sought over 50 meetings. Read the full analysis.
Panjab University's Design Innovation Centre receives an Indian patent for its 'Grass Printer' robot. This autonomous machine can cut grass at varying heights to print messages, symbols, and intricate designs on large lawns, revolutionizing automated land
Explore the high-stakes legal battles between Indian generic manufacturers and global pharma giants. Understand the impact on drug prices, accessibility, and the evolving IP landscape in India.
Hyderabad's Natco Pharma petitions Delhi High Court to revoke Novo Nordisk's semaglutide patent. The legal battle shapes India's future weight-loss drug market as 2026 patent expiry nears. Read more.
Japanese giants like MUFG, Nidec, and Polyplastics are setting up tech centres in India. Driven by an ageing population and China risk, they aim to tap India's deep talent pool for AI, cybersecurity, and engineering. Read more.
New Zealand PM Christopher Luxon hails the historic Free Trade Agreement with India as a major boost for jobs, exports, and economic growth. Key details inside.
Former Rajasthan agriculture minister Prabhu Lal Saini secures patents for three indigenous date palm varieties, ST-1, ST-2, and ST-3, boosting local cultivation. Discover his 10-year research journey.
Nxtcell India appoints Atul Vivek as CEO effective Jan 1, 2026. With 20 years of leadership experience from Realme, Samsung, and others, he will drive Alcatel's smartphone and AIoT expansion. Read more.